N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide

C43H77N3O15 — CID 129237959

IUPACN-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide
SMILESCC1CC2C[C@H](O)CC[C@]2(C)C2C[C@H](O)[C@@]3(C)C(CC[C@@H]3C(C)CCC(=O)N(CCCNC(=O)C(O)C(O)C(O)C(O)CO)CCCNC(=O)C(O)C(O)C(O)C(O)CO)C12
InChIInChI=1S/C43H77N3O15/c1-22(26-8-9-27-33-23(2)17-24-18-25(49)11-12-42(24,3)28(33)19-31(52)43(26,27)4)7-10-32(53)46(15-5-13-44-40(60)38(58)36(56)34(54)29(50)20-47)16-6-14-45-41(61)39(59)37(57)35(55)30(51)21-48/h22-31,33-39,47-52,54-59H,5-21H2,1-4H3,(H,44,60)(H,45,61)/t22?,23?,24?,25-,26-,27?,28?,29?,30?,31+,33?,34?,35?,36?,37?,38?,39?,42+,43-/m1/s1
InChIKeyDXSQOIRXVHTVKH-DTNHRPOISA-N
MW876.09 g/mol
LogP-2.65
Rot. Bonds22

About N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide

N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide (PubChem CID 129237959) has the molecular formula C43H77N3O15 and a molecular weight of 876.09 g/mol. Its IUPAC name is N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide.

Molecular Properties

Compound NameN-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide
PubChem CID129237959
Molecular FormulaC43H77N3O15
Molecular Weight876.09 g/mol
Exact Mass875.54
IUPAC NameN-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide
SMILESCC1CC2C[C@H](O)CC[C@]2(C)C2C[C@H](O)[C@@]3(C)C(CC[C@@H]3C(C)CCC(=O)N(CCCNC(=O)C(O)C(O)C(O)C(O)CO)CCCNC(=O)C(O)C(O)C(O)C(O)CO)C12
InChIInChI=1S/C43H77N3O15/c1-22(26-8-9-27-33-23(2)17-24-18-25(49)11-12-42(24,3)28(33)19-31(52)43(26,27)4)7-10-32(53)46(15-5-13-44-40(60)38(58)36(56)34(54)29(50)20-47)16-6-14-45-41(61)39(59)37(57)35(55)30(51)21-48/h22-31,33-39,47-52,54-59H,5-21H2,1-4H3,(H,44,60)(H,45,61)/t22?,23?,24?,25-,26-,27?,28?,29?,30?,31+,33?,34?,35?,36?,37?,38?,39?,42+,43-/m1/s1
InChIKeyDXSQOIRXVHTVKH-DTNHRPOISA-N
XLogP-2.65
TPSA321.27 Ų
H-Bond Donors14
H-Bond Acceptors15
Rotatable Bonds22
Heavy Atoms61
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500876.09
LogP ≤ 5-2.65
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide?
The IUPAC name of N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide (CID 129237959) is N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide.
What is the SMILES notation for N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide?
The canonical SMILES for N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide is CC1CC2C[C@H](O)CC[C@]2(C)C2C[C@H](O)[C@@]3(C)C(CC[C@@H]3C(C)CCC(=O)N(CCCNC(=O)C(O)C(O)C(O)C(O)CO)CCCNC(=O)C(O)C(O)C(O)C(O)CO)C12.
What is the InChIKey of N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide?
The InChIKey is DXSQOIRXVHTVKH-DTNHRPOISA-N. The full InChI is InChI=1S/C43H77N3O15/c1-22(26-8-9-27-33-23(2)17-24-18-25(49)11-12-42(24,3)28(33)19-31(52)43(26,27)4)7-10-32(53)46(15-5-13-44-40(60)38(58)36(56)34(54)29(50)20-47)16-6-14-45-41(61)39(59)37(57)35(55)30(51)21-48/h22-31,33-39,47-52,54-59H,5-21H2,1-4H3,(H,44,60)(H,45,61)/t22?,23?,24?,25-,26-,27?,28?,29?,30?,31+,33?,34?,35?,36?,37?,38?,39?,42+,43-/m1/s1.
What are the key properties of N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide?
N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide has a molecular weight of 876.09 g/mol, XLogP of -2.65, 22 rotatable bonds, 14 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[4-[(3R,7R,10S,12S,13R,17R)-3,12-dihydroxy-7,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl-[3-(2,3,4,5,6-pentahydroxyhexanoylamino)propyl]amino]propyl]-2,3,4,5,6-pentahydroxyhexanamide is sourced from PubChem (CID 129237959), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).